K Pharma (TSE:4896) Other Current Payables: 円16.99 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4896 K Pharma Inc TSE:4896
11 GF Score
Price 円762.00
! 1 Warning Sign
View Full Analysis

What is K Pharma Other Current Payables?

K Pharma TSE:4896 +4.81% 11 Other Current Payables is 円16.99 Mil as of Dec. 2025. GuruFocus rates TSE:4896 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

K Pharma's Other Current Payables for the quarter that ended in Dec. 2025 was 円16.99 Mil.

K Pharma's quarterly Other Current Payables declined from Jun. 2025 (円6.70 Mil) to Sep. 2025 (円1.77 Mil) but then increased from Sep. 2025 (円1.77 Mil) to Dec. 2025 (円16.99 Mil).

K Pharma's annual Other Current Payables declined from Dec. 2023 (円7.27 Mil) to Dec. 2024 (円0.00 Mil) but then increased from Dec. 2024 (円0.00 Mil) to Dec. 2025 (円16.99 Mil).

K Pharma Other Current Payables Related Terms

K Pharma Other Current Payables Historical Data

* Premium members only.

The historical data trend for K Pharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma Other Current Payables Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
-0.00 0.00 7.27 0.00 16.99

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 6.70 1.77 16.99 1.12
TSE:4896
11GF Score
K Pharma Inc TSE:4896
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

K Pharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of 円16.99 Mil mean?
K Pharma (TSE:4896) has a Other Current Payables of 円16.99 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on K Pharma and its competitors.
Is K Pharma's Other Current Payables too high?
K Pharma's current Other Current Payables is 円16.99 Mil. Overall, K Pharma has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's Other Current Payables compare to VRTX and REGN?
K Pharma's Other Current Payables of 円16.99 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on K Pharma and its competitors. K Pharma's current Other Current Payables is 円16.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current Other Current Payables of 円16.99 Mil. The current Other Current Payables is 円16.99 Mil. K Pharma's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For K Pharma (TSE:4896), the current Other Current Payables is 円16.99 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

K Pharma Business Description

Address 7-7-7 Roppongi, Tri-Seven Roppongi 8th Floor, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
11GF Score

Get the complete analysis for TSE:4896

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円762.00
Price